Page last updated: 2024-10-31

nabumetone and Dermatitis Exfoliativa

nabumetone has been researched along with Dermatitis Exfoliativa in 2 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schlienger, RG1
Bircher, AJ1
Horiuchi, Y1
Toyama, M1
Ikezawa, K1

Other Studies

2 other studies available for nabumetone and Dermatitis Exfoliativa

ArticleYear
Drug-induced erythroderma with high fever--is it drug hypersensitivity syndrome?
    The Journal of dermatology, 2003, Volume: 30, Issue:4

    Topics: Butanones; Clindamycin; Dermatitis, Exfoliative; Diagnosis, Differential; Drug Hypersensitivity; Fev

2003
Drug-induced erythroderma with high fever.
    The Journal of dermatology, 2002, Volume: 29, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Butanones; Clindamycin; Dermatitis, Exfoliative; Drug Eruptions; Fev

2002